Importantly, she said she has cut out sugary Starbucks drinks, as well as full fat sodas and chips
Additionally, a 2018 study suggested potential pancreatic cancer protection in individuals with type 2 diabetes who used incretin-based therapies over an extended period
Key Takeaways Wegovy Pill (oral semaglutide, 25 mg, Novo Nordisk) was FDA-approved for weight loss on December 22nd, 2025 with the medication expected to be available to patients in early January 2026
Suspected side effects from any medicine including unlicensed or counterfeit products should be reported to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app
Age-related intraneuronal aggregation of amyloid-beta in endosomes, mitochondria, autophagosomes, and lysosomes
Medical supervision isn't just a nice-to-have here